Abstract
The antihypertensive activity of nitrendipine analogues can be improved by properly lengthening its alkyl chain in 3- or 5-position. Nitrendipine and its seven analogues were synthesized, and their antihypertensive activities in spontaneously hypertensive rats (SHR) were evaluated by ig administration. It was found that 5-n-heptyl 3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate [(±)-5] exhibited the strongest antihypertensive effect amongst eight compounds. (+)-5-n-heptyl 3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate [(+)-5] was also prepared. Antihypertensive activities of (±)-5 and (+)-5 in SHR were compared. The results showed that (±)-5 and (+)-5 had a higher potency than nitrendipine, and (+)-isomer was 1.79-fold the raceme at a dose of 2 mg/kg.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ashimori A, Uchida T, Ohtaki Y, Tanaka M, Ohe K, Fukaya C, Watanabe M, Kagitani M, Yokoyama K (1991) Synthesis and pharmacological effects of optically active 2-[4-(4-Benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylate hydrochloride. Chem Pharm Bull 39:108–111
Baindur N, Rutledge A, Triggle DJ (1993) A homologous series of permanently charged 1,4-dihydropyridines: novel probes designed to localize drug binding sites on ion channels. J Med Chem 36:3743–3746
Fu Q, Sanbe H, Kgawa C, Kunimoto KK, Haginaka J (2003) Uniformly sized molecularly imprinted polymer for (S)-nilvadipine. Comparison of chiral recognition ability with HPLC chiral stationary phases based on a protein. Anal Chem 75:191–198
Ghorbani-Choghamarani A, Zolfigol MA, Salehi P, Ghaemi E, Madrakian E, Nasr-Isfahani H, Shahamirian M (2008) An efficient procedure for the synthesis of Hantzsch 1,4-dihydropyridines under mild conditions. Acta Chim Slov 55:644–647
Levine CB, Fahrbach KR, Frame D, Connelly JE, Estok RP, Stone LR, Ludensky V (2003) Effect of amlodipine on systolic blood pressure. Clin Ther 25:35–57
Liu F, Qiu M, Zhai SD (2010) Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: a systematic review and meta-analysis. Curr Ther Res 71:1–29
Motomura S, Wu ZJ, Hashimoto K (1993) Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables. Heart Vessels 8:16–22
Palacios F, Herran E, Rubiales G, Alonso C (2007) Regioselective synthesis of pyridines and dihydropyridines derived from β-amino acids and amino phosphonates by reaction of N-vinylic phosphazenes with α,β-unsaturated ketones. Tetrahedron 63:5669–5676
Park JY, Kim KA, Park PW, Lee OJ, Ryu JH, Lee GH, Ha MC, Kim JS, Kang SW, Lee KR (2006) Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study. Clin Ther 28:1837–1847
Peri R, Padmanabhan S, Rutledge A, Singh S, Triggle DJ (2000) Permanently charged chiral 1,4-Dihydropyridines: molecular probes of L-type calcium channels. synthesis and pharmacological characterization of methyl (ω-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists. J Med Chem 43:2906–2914
Raju P, Ravindra V, Mathad VT, Dubey PK, Reddy PP (2009) A facile, one-pot synthesis of lacidipine using in situ generation of wittig intermediates. Org Process Res Dev 13:710–715
Sabitha G, Reddy GSKK, Reddy CS, Yadav JS (2003) A novel TMSI-mediated synthesis of Hantzsch 1,4-dihydropyridines at ambient temperature. Tetrahedron Lett 44:4129–4131
Shibanuma T, Iwanami M, Okuda K, Takenaka T, Murakami M (1980) Synthesis of optically active 2-(N-benzyl-N-methylamino)ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nicardipine). Chem Pharm Bull 28:2809–2812
Tokuma YJ, Noguchi H (1995) Stereoselective pharmacokinetics of dihydropyridine calcium antagonists. J Chromatogr A 694:181–193
Trachtman H, Mahan RFJD, Portman R, Matoo IRTK, Tou C, Klibaner M (2003) Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol 18:548–553
Wehinger E, Meyer H, Knorr A (1983) Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. EP 0088276A1
Wu XY, Hu AX, Tan Y (2003) Synthesis improvement of calcium antagonist pranidipine. Chin J Appl Chem 20:1015–1017
Zhang BL, He W, Shi Xin, Huan ML, Huang QJ, Zhou SY (2010) Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. Bioorg Med Chem Lett 20:805–808
Zolfigol MA, Salehi P, Safaiee M (2006) An efficient and eco-friendly procedure for the synthesis of Hantzsch ethyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylates under mild and green conditions. Lett Org Chem 3:153–156
Acknowledgment
This study was supported financially by a 13115 project, No. 2007ZDKG-78, from Shaanxi Province, P. R. China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, K., Wang, Xm., Zhao, Yz. et al. Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of nitrendipine analogues. Med Chem Res 20, 1325–1330 (2011). https://doi.org/10.1007/s00044-010-9477-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-010-9477-0